Article
Promise of gene therapy to treat sickle cell disease
16 Oct 2018
Abstract excerpt
INTRODUCTION: Sickle cell anemia (SCA) is a hereditary blood disease caused by a single-gene mutation that affects millions of individuals world-wide. In this review, we focus on techniques to treat SCA by ex vivo genetic manipulation of hematopoietic stem/progenitor cells (HSPC), emphasizing replacement gene therapy and gene editing. AREAS COVERED: Viral transduction of an anti-sickling β-like globin gene has...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
